A logo sits outside the headquarters of Novartis AG in Basel, Switzerland. (Photographer: Gianluca Colla/Bloomberg)

A $2.1 Million Drug for a Deadly Childhood Disease Is Approved by FDA

(Bloomberg) -- A potential cure for a lethal childhood disorder -- the first of its kind in the U.S. -- is hitting the market at a cost of $2.1 million, paving the way for more therapies that bring...